REGENXBIO Inc. Class Action Lawsuit

Company: REGENXBIO Inc.

Ticker: (NASDAQ) RGNX

Class Action Period: February 9, 2022 - January 27, 2026

19 Days LeftLead Plaintiff Deadline: April 14, 2026

See If You Qualify For Monetary Reward

Join the REGENXBIO Inc. Class Action Lawsuit

There is no cost or obligation for you to submit.

The submission of this form does not create an attorney-client relationship.

CLASS ACTION PERIOD

February 9, 2022 - January 27, 2026

Allegations

Allegations

According to the complaint, defendants provided investors with material information concerning REGENXBIO’s plan to develop and commercialize its product candidate RGX-111, a one-time gene therapy for the treatment of severe Mucopolysaccharidosis Type I, also known as Hurler syndrome. Defendants’ statements included, among other things, REGENXBIO’s positive assertions of RGX-111’s future trial success based on continuing positive biomarker and safety data from the ongoing PhaseI/II study. 3. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the efficacy and safety of its RGX-111 trial study. On January 28, 2026, REGENXBIO issued a press release announcing that the FDA placed a clinical hold on its investigational gene therapy RGX-111. Defendants announced that an intraventricular CNS tumor was found in a participant treated in its RGX-111 Phase I/II study. Following this news, the price of REGENXBIO’s common stock declined from a closing market price of $13.41 per share on January 27, 2026, REGENXBIO’s stock price fell to $11.01 per share on January 28, 2026, a decline of 17.8% in the span of just a single day.

Eligibility

Eligibility

To join the lawsuit, you must have experienced a loss on REGENXBIO shares purchased within the class period specified above.

Lead Plaintiff Deadline

Lead Plaintiff Deadline

If you suffered a loss in REGENXBIO Inc. during the relevant time frame, you have until April 14, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

EXPLORE MORE CASES

Oracle Corporation

ORCL

Lead Plaintiff Deadline: April 6, 2026

Class Period: June 12, 2025 - December 16, 2025

11 Days Left

Enphase Energy, Inc.

ENPH

Lead Plaintiff Deadline: April 20, 2026

Class Period: April 22, 2025 - October 28, 2025

25 Days Left

uniQure N.V.

QURE

Lead Plaintiff Deadline: April 13, 2026

Class Period: September 24, 2025 - October 31, 2025

18 Days Left

Case Podcast